TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 64.70
+2.00 (3.19%)
Sep 8, 2026, 12:10 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 17.13 billion as of September 4, 2026. Its market cap has decreased by -22.30% in one year.
Market Cap
17.13B
Enterprise Value
16.00B
Revenue
619.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
64.70
ChartMarket Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 17.13B, an increase of 563.83%. That is a compound annual growth rate of 12.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 17.13B | 2.45% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.68B |
| CHO Pharma | 21.51B |
| Oneness Biotech | 21.41B |
| Medigen Vaccine Biologics | 20.22B |
| Ever Supreme Bio Technology | 15.81B |
| Gongwin Biopharm Holdings | 14.91B |
| EirGenix | 14.35B |
| Lumosa Therapeutics | 13.35B |